Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

被引:1063
|
作者
Bosset, JF
Gignoux, M
Triboulet, JP
Tiret, E
Mantion, G
Elias, D
Lozach, P
Ollier, JC
Pavy, JJ
Mercier, M
Sahmoud, T
机构
[1] UNIV HOSP COTE NACRE, CAEN, FRANCE
[2] UNIV HOSP C HURRIEZ, LILLE, FRANCE
[3] UNIV HOSP ST ANTOINE, PARIS, FRANCE
[4] INST GUSTAVE ROUSSY, VILLEJUIF, FRANCE
[5] UNIV HOSP A MORVAN, BREST, FRANCE
[6] UNIV HOSP, SCHILTIGHEIM, FRANCE
[7] EUROPEAN ORG RES TREATMENT CANC, CTR DATA, BRUSSELS, BELGIUM
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1997年 / 337卷 / 03期
关键词
D O I
10.1056/NEJM199707173370304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background We conducted a multicenter, randomized trial to compare preoperative chemoradiotherapy followed by surgery with surgery alone in patients with stage I and II squamous-cell cancer of the esophagus. Methods The preoperative combined therapy consisted of two one-week courses; each involved radio therapy, in a dose of 18.5 Gy delivered in five fractions of 3.7 Gy each, and 80 mg of cisplatin per square meter of body-surface area, administered 0 to 2 days before the first day of radiotherapy. The surgical plan included one-stage en bloc esophagectomy and proximal gastrectomy by the abdominal and right thoracic routes, to be performed immediately after randomization in the group assigned to surgery alone and two to four weeks after the completion of preoperative chemoradiotherapy in the group assigned to combined therapy. Results A total of 297 patients entered the study; 11 were found to be ineligible, and 4 were lost to fol low-up. Of the remaining 282, 139 were assigned to surgery alone and 143 to combined therapy. After a median follow-up of 55.2 months, no significant difference in overall survival was observed; the median survival was 18.6 months for both groups. As compared with the group treated with surgery alone, the group treated preoperatively had longer disease-free survival (P=0.003), a longer interval free of local disease (P=0.01), a lower rate of cancer-related deaths (P=0.002), and a higher frequency of curative resection (P=0.017). However, there were more postoperative deaths (P=0.012) in the group treated preoperatively with chemoradiotherapy. Three prognostic factors were found to influence survival in a multivariate analysis: the disease stage, based on computed tomography; the location of the tumor; and whether the surgical resection was curative. Conclusions In patients with squamous-cell esophageal cancer, preoperative chemoradiotherapy did not improve overall survival, but it did prolong disease-free survival and survival free of local disease. (C)1997, Massachusetts Medical Society.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 50 条
  • [1] Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus:: FFCD 9102
    Bedenne, Laurent
    Michel, Pierre
    Bouche, Olivier
    Milan, Chantal
    Mariette, Christophe
    Conroy, Thierry
    Pezet, Denis
    Roullet, Bernard
    Seitz, Jean-Francois
    Herr, Jean-Philippe
    Paillot, Bernard
    Arveux, Patrick
    Bonnetain, Franck
    Binquet, Christine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) : 1160 - 1168
  • [2] Preoperative chemotherapy followed by esophagectomy compared with surgery alone in the treatment of squamous cell carcinoma of the esophagus
    Lizoain, JLH
    Cienfuegos, JA
    Pardo, F
    Regueira, FM
    Sola, I
    Aristu, J
    Azinovic, I
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1998, 90 (04) : 283 - 290
  • [3] COMBINED CHEMOTHERAPY AND RADIOTHERAPY, FOLLOWED OR NOT BY SURGERY, IN SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS
    DEPREE, C
    AAPRO, MS
    SPILIOPOULOS, A
    POPOWSKI, Y
    MERMILLOD, B
    MIRIMANOFF, RO
    ALBERTO, P
    [J]. ANNALS OF ONCOLOGY, 1995, 6 (06) : 551 - 557
  • [4] PROSPECTIVE COMPARISON OF SURGERY ALONE AND CHEMORADIOTHERAPY WITH SELECTIVE SURGERY IN RESECTABLE SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS
    Ariga, Hisanori
    Nemoto, Kenji
    Miyazaki, Shukichi
    Yoshioka, Takashi
    Ogawa, Yohishiro
    Sakayauchi, Toru
    Jingu, Keiichi
    Miyata, Go
    Onodera, Ko
    Ichikawa, Hirofumi
    Kamei, Takashi
    Kato, Shunsuke
    Ishioka, Chikashi
    Satomi, Susumu
    Yamada, Shogo
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 348 - 356
  • [5] SURGERY OF SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS
    SIEWERT, JR
    FINK, U
    BECKURTS, KTE
    RODER, JD
    [J]. ANNALS OF ONCOLOGY, 1994, 5 : S1 - S7
  • [6] A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus
    Yang, H.
    Fu, J.
    Liu, M.
    Chen, Y.
    Chen, Z.
    Zhu, C.
    Yang, H.
    Fang, W.
    Wang, J.
    Yu, Z.
    Pang, Q.
    Mao, W.
    Zheng, X.
    Xiang, J.
    Yang, H.
    Han, Y.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [7] A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus.
    Yang, Hong
    Fu, Jianhua
    Liu, Mengzhong
    Fang, Wenteo
    Wang, Jiaming
    Chen, Yuping
    Chen, Zhijian
    Zhu, Chengchu
    Xiang, Jiaqing
    Yang, Huanjun
    Yu, Zhengtao
    Pang, Qingsong
    Mao, Weimin
    Zheng, Xiao
    Han, Yongtao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution
    Natsugoe, S.
    Okumura, H.
    Matsumoto, M.
    Uchikado, Y.
    Setoyama, T.
    Yokomakura, N.
    Ishigami, S.
    Owaki, T.
    Aikou, T.
    [J]. DISEASES OF THE ESOPHAGUS, 2006, 19 (06) : 468 - 472
  • [9] Outcome of the nonrandomized patients in the FFCD 9102 trial: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus
    Jouve, J.
    Michel, P.
    Mariette, C.
    Bonnetain, F.
    Bouche, O.
    Conroy, T.
    Pezet, D.
    Burtin, P.
    Segol, P.
    Bedenne, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
    Van Heijl M.
    Van Lanschot J.J.B.
    Koppert L.B.
    Van Berge Henegouwen M.I.
    Muller K.
    Steyerberg E.W.
    Van Dekken H.
    Wijnhoven B.P.L.
    Tilanus H.W.
    Richel D.J.
    Busch O.R.C.
    Bartelsman J.F.
    Koning C.C.E.
    Offerhaus G.J.
    Van Der Gaast A.
    [J]. BMC Surgery, 8 (1)